Related references
Note: Only part of the references are listed.Lipid-modifying therapy and attainment of cholesterol goals in Hungary - The return on expenditure achieved for lipid therapy (REALITY) study
Gyoergy Paragh et al.
CLINICAL DRUG INVESTIGATION (2007)
Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease
WT Lester et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2006)
Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success
K Kawamoto et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease
SS Nag et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Randomized, controlled trial of secondary prevention of coronary sclerosis in normocholesterolemic patients using pravastatin: final 5-year angiographic follow-up of the Prevention of Coronary Sclerosis (PCS) study
T Nakagawa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2004)
Improving guideline adherence -: A randomized trial evaluating strategies to increase β-blocker use in heart failure
M Ansari et al.
CIRCULATION (2003)
AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update - Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases
TA Pearson et al.
CIRCULATION (2002)
A diabetes report card for the United States: Quality of care in the 1990s
JB Saaddine et al.
ANNALS OF INTERNAL MEDICINE (2002)
Assessment of hypercholesterolemia control in a managed care organization
RJ Straka et al.
PHARMACOTHERAPY (2001)
Share Paper
